BAY32-5915
Code | Size | Price |
---|
TAR-T20770-1mL | 1 mL * 10 mM (in DMSO) | £95.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T20770-100mg | 100mg | £104.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
BAY32-5915 is a selective inhibitor of IKKalpha.
CAS:
1571-30-8
Formula:
C10H7NO3
Molecular Weight:
189.17
Pathway:
NF-κb
Purity:
0.98
SMILES:
OC(=O)c1ccc2cccc(O)c2n1
Target:
IκB/IKK
References
1. Pletz N, et al. Doxorubicin-induced activation of NF-?B in melanoma cells is abrogated by inhibition of IKK?, but not by a novel IKK? inhibitor. Exp Dermatol. 2012 Apr;21(4):301-4.